Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
批准号:
10911510
负责人:
MICHAEL C BASSIK
金额:
$6.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-14 至 2026-08-31
关键词:
Breast Cancer CellBreast Cancer cell lineCRISPR interferenceCRISPR screenCancer ModelCell CommunicationDevelopmentDrug TargetingDrug resistanceEffectivenessEstrogen receptor positiveGrowthImmune systemIn VitroMacrophageMagnetismMalignant NeoplasmsMetastatic breast cancerNeoplasm MetastasisPhagocytosisPhenotypePropertyResistanceResistance developmentSystembreast cancer progressioncancer cellcancer therapygenome-widehormone therapyin vivoneoplastic cellparent grantrelapse risktargeted treatmentthree dimensional cell culturetumortumor microenvironment
中文摘要
家长资助项目3的总结:控制乳房的因素的系统表征
英文摘要
Summary of the Parent Grant Project 3: Systematic characterization of factors controlling breast
cancer progression and resistance
Two central challenges limit effectiveness of cancer therapies and enable metastasis: development of intrinsic
resistance to targeted drugs, and development of resistance to recognition and destruction of cancer cells by
the immune system. Traditional in vitro cancer models have been limited in scale and often lack key properties
of the tumor microenvironment. We recently developed a scalable cancer spheroid system that enabled the
first genome-wide CRISPR screens in 3D culture; phenotypes in this system much better reflect in vivo tumors
(Han et al., 2020). In addition, we developed a magnetic separation strategy to rapidly identify regulators of
phagocytosis by macrophages (Haney et al., 2018), and have successfully extended this strategy to study
macrophage-tumor cell interactions. Here we propose to use these systems to identify regulators of
resistance to targeted and endocrine therapies and macrophage killing in metastatic breast cancer.
Aim 1: Identify critical drivers of growth and drug resistance in high relapse risk ER+ breast cancer cell
lines and PDOs using CRISPRi/a screen
Aim 2: Systematic identification and characterization of factors limiting macrophage phagocytosis of breast
cancer cells
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
-
批准号:10632140
-
项目类别:
-
资助金额:$99.26万
-
财政年份:2021
-
负责人:MICHAEL C BASSIK
-
依托单位:
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
-
批准号:10704691
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2021
-
负责人:MICHAEL C BASSIK
-
依托单位:
Project 3: Systematic characterization of factors controlling breast cancer progression and resistance
-
批准号:10272391
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2021
-
负责人:MICHAEL C BASSIK
-
依托单位:
High-throughput development and characterization of compact tools for transcriptional and chromatin perturbations
-
批准号:10276866
-
项目类别:
-
资助金额:$99.24万
-
财政年份:2021
-
负责人:MICHAEL C BASSIK
-
依托单位:
High-throughput systematic characterization of regulatory element function
-
批准号:10238366
-
项目类别:
-
资助金额:$103.26万
-
财政年份:2020
-
负责人:MICHAEL C BASSIK
-
依托单位:
Development of novel protein-based therapeutics for lung cancer
-
批准号:10373026
-
项目类别:
-
资助金额:$55.26万
-
财政年份:2018
-
负责人:MICHAEL C BASSIK
-
依托单位:
Development of novel protein-based therapeutics for lung cancer
-
批准号:10133002
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2018
-
负责人:MICHAEL C BASSIK
-
依托单位:
Development of novel protein-based therapeutics for lung cancer
-
批准号:9894638
-
项目类别:
-
资助金额:$56.34万
-
财政年份:2018
-
负责人:MICHAEL C BASSIK
-
依托单位:
High-throughput systematic characterization of regulatory element function
-
批准号:9247643
-
项目类别:
-
资助金额:$131.18万
-
财政年份:2017
-
负责人:MICHAEL C BASSIK
-
依托单位:
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
-
批准号:9315124
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2015
-
负责人:MICHAEL C BASSIK
-
依托单位:
Accelerating drug development and repurposing using systematic genetic interactio
-
批准号:8757890
-
项目类别:
-
资助金额:$240.75万
-
财政年份:2014
-
负责人:MICHAEL C BASSIK
-
依托单位:
海外基金